FDA Approved: JENTADUETO XR — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved JENTADUETO XR (linagliptin and metformin hydrochloride extended-release) under an original application for adults with type 2 diabetes to impro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JENTADUETO XR (Linagliptin and metformin hydrochloride)

Snippet

ORIG AP for JENTADUETO XR (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE)